Healthcare

The Bengaluru-based startup has secured fresh capital to scale its preventive health platform, utilizing a proprietary AI memory layer to bring affordable, personalised wellness coaching to India’s smaller cities.

The Bengaluru and Cambridge-based biotech firm has secured fresh capital to complete Phase 1 trials for its novel Natural Killer (NK) cell checkpoint inhibitor targeting solid tumors.

By combining physical neighborhood clinics with digital growth-tracking tools, the Bengaluru-based startup is capturing high-LTV, recurring revenue streams previously monopolized by traditional multi-specialty hospitals.

By leveraging its localized GMP manufacturing infrastructure, the Bengaluru-based biotechnology firm is successfully compressing the $500,000 cost of global CAR-T treatments into an affordable, indigenously built cell therapy for emerging markets.

India's largest drugmaker leverages a heavy debt structure to acquire the Merck spinoff, securing immediate dominance in women's health and a powerful foothold in the lucrative biosimilars market.

The Mumbai-based private equity firm has exceeded its initial $250 million target, drawing heavy commitments from global institutional investors to deploy capital across India's growing healthcare delivery and pharma manufacturing sectors.